{"cluster": 48, "subcluster": 75, "abstract_summ": "We divided patients into groups and included 2 control groups (individuals with normal renal functions): group I included COVID-19-positive patients with normal renal function, group II included COVID-19-positive hemodialysis patients, group III included COVID-19-negative hemodialysis patients, and group IV included COVID-19-negative patients with normal renal function.RESULTS: From Jan 17, 2020, to Feb 1, 2020, 85 confirmed COVID-19 patients were enrolled, including 16 in the progression group and 69 in the stable mild group.Conclusions We designed a clinically predictive tool which is easy to use for assessing the progression risk of COVID-19, and the NLP score could be used to facilitate patient stratification management.Methods In this retrospectively analyzed cohort, 141 confirmed COVID-19 patients were enrolled in Taizhou Public Health Medical Center, Taizhou Hospital, Zhejiang Province, China, from January 17, 2020 to February 26, 2020.Although it has been reported that some COVID-19 patients showed elevated liver biochemistries, there are few studies regarding clinical features and prognosis of these patients.", "title_summ": "Risk stratification of hospitalized COVID-19 patients through comparative studies of laboratory results with influenzaVirologic and clinical characteristics for prognosis of severe COVID-19: a retrospective observational study in Wuhan, ChinaPreliminary study to identify severe from moderate cases of COVID-19 using NLR&RDW-SD combination parameterPredicting COVID-19 malignant progression with AI techniquesElevated serum IgM levels indicate poor outcome in patients with coronavirus disease 2019 pneumonia: A retrospective case-control studyClinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysisLactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control studyCharacteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experienceAnalysis of mortality in patients of COVID-19: clinical and laboratory parametersAnalysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus diseaseClinical features and multidisciplinary treatment outcome of COVID-19 pneumonia: A report of three casesPredictive factors for disease progression in hospitalized patients with Coronavirus Disease 2019 in Wuhan, ChinaIncidence and Immunologic Analysis of Coronavirus Disease (COVID-19) in Hemodialysis Patients:A Single-Center Experience.Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus.Serum IgM against SARS-CoV-2 correlates with in-hospital mortality in severe/critical patients with COVID-19 in Wuhan, China.The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.", "title_abstract_phrases": "We divided patients into groups and included 2 control groups (individuals with normal renal functions): group I included COVID-19-positive patients with normal renal function, group II included COVID-19-positive hemodialysis patients, group III included COVID-19-negative hemodialysis patients, and group IV included COVID-19-negative patients with normal renal function.The proposed model can be effectively used for finding out the mild patients who are easy to deteriorate into severe/critical cases, so that such patients get timely treatments while alleviating the limitations of medical resources.RESULTS: From Jan 17, 2020, to Feb 1, 2020, 85 confirmed COVID-19 patients were enrolled, including 16 in the progression group and 69 in the stable mild group.Methods In this retrospectively analyzed cohort, 141 confirmed COVID-19 patients were enrolled in Taizhou Public Health Medical Center, Taizhou Hospital, Zhejiang Province, China, from January 17, 2020 to February 26, 2020.Although it has been reported that some COVID-19 patients showed elevated liver biochemistries, there are few studies regarding clinical features and prognosis of these patients."}